On December 29, 2017, the Ministry of Health issued Circular 51/2017/TT-BYT guiding the prevention, diagnosis, and management of anaphylaxis.
According to Circular 51, medical examination and treatment facilities, doctors, and medical staff must ensure the following anaphylaxis prevention principles:
- Prescribe the most appropriate route of drug administration, only injecting when other routes cannot be used.- Do not test reactions for all drugs unless prescribed by a doctor.- Do not prescribe drugs or recommend the use of drugs or allergens known to cause anaphylaxis for the patient.- All cases of anaphylaxis must be reported to the National Center for Drug Information and Adverse Drug Reaction Monitoring or the Ho Chi Minh City Regional Center for Drug Information and Adverse Drug Reaction Monitoring.- Doctors, prescribers, or other authorized medical staff must thoroughly investigate the patient's allergy history to drugs and allergens before prescribing or recommending drug use.- When the drug or allergen causing anaphylaxis has been identified, doctors and medical staff must issue the patient an allergy monitoring card clearly stating the name of the drug or allergen causing the allergy.
See the management of defensive procedures at Circular 51/2017/TT-BYT, effective from February 15, 2018.
- Thanh Lam -
Address: | 19 Nguyen Gia Thieu, Vo Thi Sau Ward, District 3, Ho Chi Minh City |
Phone: | (028) 7302 2286 |
E-mail: | [email protected] |